Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon‐α treatment in HBeAg‐positive chronic hepatitis B patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9071|90|4|721-729

ISSN： 0146-6615

Source： JOURNAL OF MEDICAL VIROLOGY, Vol.90, Iss.4, 2018-04, pp. : 721-729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vitamin D‐related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 11, 2015-11 ,pp. : 1904-1912

John Wiley & Sons Inc

Access to resources Recommend Favorite

HBsAg spontaneous seroclearance in a cohort of HBeAg‐seronegative patients with chronic hepatitis B virus infection

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 88, Iss. 1, 2016-01 ,pp. : 79-85

John Wiley & Sons Inc

Access to resources Recommend Favorite

HBeAg‐negative chronic hepatitis patients should be monitored more strictly: A cross‐sectional retrospective study on antiviral treatment‐naïve patients

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 10, 2015-10 ,pp. : 1682-1688

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype‐4 chronic hepatitis C patients

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 88, Iss. 12, 2016-12 ,pp. : 2170-2178

John Wiley & Sons Inc

Access to resources Recommend Favorite

IFN‐λ gene polymorphisms as predictive factors in chronic hepatitis C treatment‐naive patients without access to protease inhibitors

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 10, 2015-10 ,pp. : 1702-1715

John Wiley & Sons Inc

Access to resources Recommend Favorite